About The Study: In this study, major adverse cardiovascular event risk varied significantly by medication class, with most protection achieved with sustained treatment with glucagon-like peptide-1 ...

You pick up your prescription, follow the dosage, and trust that it will do its job. For many people, that routine rarely raises concern. But emerging research suggests that some widely used ...

First-in-class drugs can be highly innovative because of their novel mechanisms of action, but they also carry uncertainty in the absence of clinical experience. To understand how such drugs advance ...